sales@businessmarketinsights.com +1 646 791 7070 | +91-020 69018608

Artificial Intelligence in Drug Discovery Market Size & Forecast

Historic: 2022-2024 Base Year: 2025 Forecast: 2026–2033
US$ 4.68 Billion
Market Size 2025 · Base Year
US$ 12.63 Billion
Projected Market Size by 2033
13.21%
CAGR · 2026–2033
SHARE
BMIPUB00036783 56+ Countries Covered 10 Major Companies Profiled PEST & SWOT Analysis Competitive Heat Map
At a Glance

Report Coverage

56 +
Countries
56+ countries across North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa
12
Year Assessment
Comprehensive Market Analysis Covering 3 Years of Historical Data (2022–2024), Base Year (2025), and 8-Year Forecast (2026–2033)
10 +
Major Players
Major companies profiled including Microsoft Corporation, Schrodinger, Inc., Cresset, IBM Corporation, Atomwise, Inc.
350
Report Pages
Pages of deep-dive analysis with PEST, SWOT, competitive heat maps and datasets
What's Fueling Growth

Market Drivers

  • Growing Adoption of AI in Pharmaceutical Research

  • Increasing Need for Faster Drug Discovery

  • Rising Investments in AI-Based Drug Development

Where Growth Opportunities Exist

Key Opportunities

  • Increasing AI Collaborations with Pharma Companies

  • Growing Demand for Precision Drug Discovery

  • Rising Development of Rare Disease Therapies

What Could Slow It Down

Market Restraints

  • Data Privacy and Regulatory Challenges

  • High AI Deployment Costs

  • Limited Availability of High-Quality Datasets

Market Segmentation

Coverage by Segment

Drug Type

Small Molecule
Large Molecule

Offering

Software
Services

Technology

Machine Learning
Natural Language Processing
Others

Application

Endocrinology
Cardiology
Oncology
Geographic Breakdown

Regional Intelligence

NA North America
EU Europe
APAC Asia-Pacific
SCA South & Central America
MEA Middle East & Africa
Competitive Landscape

Major Market Players

Listed for reference — companies are not ranked in any particular order.

Microsoft Corporation
Schrodinger, Inc.
Cresset
IBM Corporation
Atomwise, Inc.
Insilico Medicine
Exscientia plc
BenevolentAI
Aria Pharmaceuticals, Inc.
Integral BioSciences Pvt. Ltd.
What's Inside

Report Scope & Deliverables

Market Size 2025 US$ 4.68 Billion
Market Size 2033 US$ 12.63 Billion
CAGR 2026–2033 13.21%
Segments By Drug Type (Small Molecule, Large Molecule)  |  By Offering (Software, Services)  |  By Technology (Machine Learning, Natural Language Processing, Others)
Geographies North America (US, Canada, Mexico)  ·  Europe (Germany, Italy, France, U.K., Spain, Belgium, Netherlands, Luxembourg, Norway, Finland, Denmark, Sweden, Switzerland, Austria, Greece, Portugal, Russia, Poland, Romania, Czech Republic, Ukraine, Slovakia, Bulgaria)  ·  Asia-Pacific (China, Japan, South Korea, India, Australia, New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Taiwan, Bangladesh)  ·  South and Central America (Brazil, Argentina, Chile, Colombia, Peru)  ·  Middle East and Africa (Saudi Arabia, United Arab Emirates, Kuwait, Bahrain, Qatar, Oman, Turkiye, South Africa, Egypt, Nigeria, Algeria)
Deliverables Historical analysis with CAGR · PEST & SWOT analysis · Market Size at Global, Regional, and Country Levels · Competitive heat map · Company profiles · Excel dataset
Report Code BMIPUB00036783
Lead Analyst Krishna Sunthwal — Analyst, Research · View Profile
With Full Report Access

Gain actionable insights with 350 pages of in-depth Artificial Intelligence in Drug Discovery Market, including historical trends, 8-year market forecasts, SWOT analysis, competitive landscapes, and downloadable Excel datasets in a single comprehensive package.